Form 4: AIM ImmunoTech Director Acquires Shares in Lieu of Cash Compensation

Director Stewart Appelrouth acquired 8,768 shares of AIM ImmunoTech Inc. common stock on December 31, 2024, in lieu of cash compensation under the company's Cash Conservation Plan.

Summary

• On December 31, 2024, Stewart Appelrouth, a director of AIM ImmunoTech Inc., acquired 8,768 shares of common stock.
• The acquisition was made in lieu of director compensation, as part of the company's Cash Conservation Plan.
• Following the transaction, Appelrouth's direct ownership in AIM ImmunoTech Inc. increased to 388,729 shares.
• The price of the shares acquired was $0.198.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While a director taking shares can be seen as a positive sign, it's also indicative of the company's need to conserve cash.

Positives

• The director's acceptance of shares in lieu of cash compensation demonstrates confidence in the company's future prospects.
• The Cash Conservation Plan helps the company manage its cash flow.

Industry Context

Directors sometimes take shares in lieu of cash to conserve cash for the company. This is a common practice in smaller companies or those facing financial constraints.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively, as it aligns interests.
• Employees may be indirectly affected by the Cash Conservation Plan, as it could impact salary increases or bonuses.

Key Dates

Keywords

AIM ImmunoTech, Director, Stewart Appelrouth, Share Acquisition, Cash Conservation Plan, Common Stock, Compensation